

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.93225986 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.77537725 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.77537725 |
| 4 | positive thymic T cell selection (GO:0045059) | 4.09411379 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.05770534 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.05770534 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.05770534 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.05770534 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.05770534 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.05770534 |
| 11 | detection of other organism (GO:0098543) | 3.93684337 |
| 12 | response to muramyl dipeptide (GO:0032495) | 3.90961140 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.87843542 |
| 14 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.79315210 |
| 15 | detection of bacterium (GO:0016045) | 3.76274617 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 3.68992967 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.61723921 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.61663792 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.59759716 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.59759716 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 3.57068721 |
| 22 | detection of external biotic stimulus (GO:0098581) | 3.49700429 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.42474017 |
| 24 | apoptotic cell clearance (GO:0043277) | 3.41702572 |
| 25 | regulation of mast cell degranulation (GO:0043304) | 3.41637623 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.35634760 |
| 27 | regulation of leukocyte degranulation (GO:0043300) | 3.32342743 |
| 28 | NIK/NF-kappaB signaling (GO:0038061) | 3.25517898 |
| 29 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.25297927 |
| 30 | negative thymic T cell selection (GO:0045060) | 3.22528007 |
| 31 | positive regulation of B cell differentiation (GO:0045579) | 3.22396406 |
| 32 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.20544563 |
| 33 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.17658598 |
| 34 | thymic T cell selection (GO:0045061) | 3.16523267 |
| 35 | negative T cell selection (GO:0043383) | 3.13911510 |
| 36 | detection of biotic stimulus (GO:0009595) | 3.13334726 |
| 37 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.13049443 |
| 38 | positive regulation of histone deacetylation (GO:0031065) | 3.11383230 |
| 39 | negative regulation of interleukin-12 production (GO:0032695) | 3.11158902 |
| 40 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.09662830 |
| 41 | cortical actin cytoskeleton organization (GO:0030866) | 3.08475001 |
| 42 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05805512 |
| 43 | regulation of integrin activation (GO:0033623) | 3.02819398 |
| 44 | macrophage activation involved in immune response (GO:0002281) | 3.02421670 |
| 45 | tolerance induction (GO:0002507) | 3.00102049 |
| 46 | positive T cell selection (GO:0043368) | 2.99906274 |
| 47 | macrophage activation (GO:0042116) | 2.99807849 |
| 48 | T-helper 1 type immune response (GO:0042088) | 2.98150399 |
| 49 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.95836837 |
| 50 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.94741763 |
| 51 | response to type I interferon (GO:0034340) | 2.92163682 |
| 52 | cellular response to type I interferon (GO:0071357) | 2.91967516 |
| 53 | type I interferon signaling pathway (GO:0060337) | 2.91967516 |
| 54 | positive regulation of interferon-alpha production (GO:0032727) | 2.90608261 |
| 55 | negative regulation of granulocyte differentiation (GO:0030853) | 2.90146758 |
| 56 | defense response to protozoan (GO:0042832) | 2.88870722 |
| 57 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.88194497 |
| 58 | natural killer cell differentiation (GO:0001779) | 2.87530820 |
| 59 | B cell receptor signaling pathway (GO:0050853) | 2.86748397 |
| 60 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.84663395 |
| 61 | response to laminar fluid shear stress (GO:0034616) | 2.83078447 |
| 62 | response to protozoan (GO:0001562) | 2.82115598 |
| 63 | positive regulation of mast cell activation (GO:0033005) | 2.82102751 |
| 64 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.80992992 |
| 65 | neutrophil activation involved in immune response (GO:0002283) | 2.80493704 |
| 66 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.80485568 |
| 67 | mannose metabolic process (GO:0006013) | 2.79760628 |
| 68 | leukocyte aggregation (GO:0070486) | 2.79306071 |
| 69 | modulation by symbiont of host cellular process (GO:0044068) | 2.79056243 |
| 70 | regulation of B cell differentiation (GO:0045577) | 2.78907162 |
| 71 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.78249175 |
| 72 | pinocytosis (GO:0006907) | 2.78226399 |
| 73 | negative regulation of T cell mediated immunity (GO:0002710) | 2.77361554 |
| 74 | microglial cell activation (GO:0001774) | 2.76792777 |
| 75 | T cell migration (GO:0072678) | 2.76606482 |
| 76 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.76555288 |
| 77 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.76184258 |
| 78 | regulation of interferon-alpha production (GO:0032647) | 2.76128634 |
| 79 | regulation of antigen processing and presentation (GO:0002577) | 2.74778851 |
| 80 | respiratory burst (GO:0045730) | 2.74622126 |
| 81 | T cell selection (GO:0045058) | 2.74465635 |
| 82 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.74018514 |
| 83 | cell adhesion mediated by integrin (GO:0033627) | 2.72995834 |
| 84 | regulation of mast cell activation (GO:0033003) | 2.72148788 |
| 85 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.68099817 |
| 86 | regulation of macrophage cytokine production (GO:0010935) | 2.67639991 |
| 87 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.65867379 |
| 88 | histone H3-K4 trimethylation (GO:0080182) | 2.65715102 |
| 89 | regulation of regulated secretory pathway (GO:1903305) | 2.63575378 |
| 90 | I-kappaB phosphorylation (GO:0007252) | 2.63158923 |
| 91 | germinal center formation (GO:0002467) | 2.57395448 |
| 92 | positive regulation of mast cell degranulation (GO:0043306) | 2.56344436 |
| 93 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.56344436 |
| 94 | cortical cytoskeleton organization (GO:0030865) | 2.56301561 |
| 95 | immunoglobulin mediated immune response (GO:0016064) | 2.56085560 |
| 96 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.55146828 |
| 97 | positive regulation of leukocyte degranulation (GO:0043302) | 2.54923488 |
| 98 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.54891247 |
| 99 | response to host (GO:0075136) | 2.54891247 |
| 100 | response to host defenses (GO:0052200) | 2.54891247 |
| 101 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.54742770 |
| 102 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.53245673 |
| 103 | amino sugar catabolic process (GO:0046348) | 2.52920882 |
| 104 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.52898753 |
| 105 | positive regulation of p38MAPK cascade (GO:1900745) | 2.52396901 |
| 106 | regulation of tolerance induction (GO:0002643) | 2.52066807 |
| 107 | neutrophil activation (GO:0042119) | 2.51900639 |
| 108 | response to host immune response (GO:0052572) | 2.49949553 |
| 109 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.49949553 |
| 110 | leukocyte cell-cell adhesion (GO:0007159) | 2.48541733 |
| 111 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.47391981 |
| 112 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.47320335 |
| 113 | natural killer cell mediated immunity (GO:0002228) | 2.47320335 |
| 114 | response to peptidoglycan (GO:0032494) | 2.46563759 |
| 115 | NLS-bearing protein import into nucleus (GO:0006607) | 2.45893339 |
| 116 | granulocyte activation (GO:0036230) | 2.43312158 |
| 117 | substrate-dependent cell migration (GO:0006929) | 2.41504889 |
| 118 | growth hormone receptor signaling pathway (GO:0060396) | 2.41376019 |
| 119 | response to fluid shear stress (GO:0034405) | 2.38587867 |
| 120 | B cell homeostasis (GO:0001782) | 2.38396985 |
| 121 | regulation of ARF GTPase activity (GO:0032312) | 2.38217732 |
| 122 | neutrophil mediated immunity (GO:0002446) | 2.36289385 |
| 123 | protein localization to endosome (GO:0036010) | 2.35820045 |
| 124 | histone H3-K4 methylation (GO:0051568) | 2.33912556 |
| 125 | myeloid cell activation involved in immune response (GO:0002275) | 2.32021558 |
| 126 | cellular extravasation (GO:0045123) | 2.31807680 |
| 127 | negative regulation of interleukin-6 production (GO:0032715) | 2.31152205 |
| 128 | endodermal cell differentiation (GO:0035987) | 2.30532451 |
| 129 | heterotypic cell-cell adhesion (GO:0034113) | 2.29646635 |
| 130 | myeloid dendritic cell activation (GO:0001773) | 2.29532170 |
| 131 | myeloid dendritic cell differentiation (GO:0043011) | 2.27897236 |
| 132 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.27776039 |
| 133 | positive regulation of antigen processing and presentation (GO:0002579) | 2.26868423 |
| 134 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.26847194 |
| 135 | integrin-mediated signaling pathway (GO:0007229) | 2.25245500 |
| 136 | nuclear pore complex assembly (GO:0051292) | 2.25102726 |
| 137 | germ cell migration (GO:0008354) | 2.22478617 |
| 138 | regulation of cholesterol storage (GO:0010885) | 2.22129875 |
| 139 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.20862305 |
| 140 | negative regulation of phagocytosis (GO:0050765) | 2.20138560 |
| 141 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.19970389 |
| 142 | regulation of T cell tolerance induction (GO:0002664) | 2.18489156 |
| 143 | receptor catabolic process (GO:0032801) | 2.18141684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.13201041 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.88162013 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.52149328 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.46349871 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.28679943 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.21467004 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.13121743 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.89179683 |
| 9 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.88256925 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.78287175 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.69023489 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.63127991 |
| 13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.61281538 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57407850 |
| 15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.50970118 |
| 16 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.38685544 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.29791561 |
| 18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.23995643 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.21404796 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.21094818 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.21031260 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.19035136 |
| 23 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.18515546 |
| 24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.17062643 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.15186970 |
| 26 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.09021831 |
| 27 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.03994412 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.02624836 |
| 29 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.01777084 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.01395037 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.00774892 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98206074 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.96335825 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.95910845 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.92358226 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.86864751 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.83146219 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.82261868 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79079996 |
| 40 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.78600082 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.75843069 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73171520 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72703788 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.68469954 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.64350229 |
| 46 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.53666269 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.53603313 |
| 48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.50477447 |
| 49 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.50280980 |
| 50 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.47834936 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41462802 |
| 52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.36933094 |
| 53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36766481 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35176154 |
| 55 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35039634 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34863813 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33772175 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.33735003 |
| 59 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.32685458 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32063376 |
| 61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31944764 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31579858 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30833087 |
| 64 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.24002071 |
| 65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.23741633 |
| 66 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18743527 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17445672 |
| 68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17145718 |
| 69 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16204207 |
| 70 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13934390 |
| 71 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.13445365 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13058731 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12137608 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12057935 |
| 75 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11409999 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10594554 |
| 77 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10335340 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10013295 |
| 79 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.09104051 |
| 80 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.07600176 |
| 81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06536272 |
| 82 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06504002 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06154287 |
| 84 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05871780 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05307089 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05178616 |
| 87 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01852239 |
| 88 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01803254 |
| 89 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01386570 |
| 90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01376095 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00395054 |
| 92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99896792 |
| 93 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99884331 |
| 94 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99081838 |
| 95 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99003778 |
| 96 | ATF3_27146783_Chip-Seq_COLON_Human | 0.98132680 |
| 97 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97343368 |
| 98 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97201095 |
| 99 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96664000 |
| 100 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96589033 |
| 101 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96589033 |
| 102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96545101 |
| 103 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96183336 |
| 104 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96049640 |
| 105 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95785599 |
| 106 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95781648 |
| 107 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95436558 |
| 108 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.94545688 |
| 109 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93209603 |
| 110 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.93182411 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92684160 |
| 112 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.91807148 |
| 113 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90386883 |
| 114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89335426 |
| 115 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.86835926 |
| 116 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.86545309 |
| 117 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86065531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.26438960 |
| 2 | MP0003303_peritoneal_inflammation | 3.52741493 |
| 3 | MP0003300_gastrointestinal_ulcer | 2.95842042 |
| 4 | MP0003724_increased_susceptibility_to | 2.89164787 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.78294331 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.56559807 |
| 7 | MP0009278_abnormal_bone_marrow | 2.53126769 |
| 8 | MP0004510_myositis | 2.50621167 |
| 9 | MP0003436_decreased_susceptibility_to | 2.39163972 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 2.34520910 |
| 11 | MP0000685_abnormal_immune_system | 2.34472622 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.30634618 |
| 13 | MP0003566_abnormal_cell_adhesion | 2.28766091 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.28634292 |
| 15 | MP0005076_abnormal_cell_differentiation | 2.23835687 |
| 16 | MP0005387_immune_system_phenotype | 2.12413234 |
| 17 | MP0001790_abnormal_immune_system | 2.12413234 |
| 18 | MP0005451_abnormal_body_composition | 2.10182838 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.10020160 |
| 20 | MP0001800_abnormal_humoral_immune | 2.06323803 |
| 21 | MP0002396_abnormal_hematopoietic_system | 2.02763644 |
| 22 | MP0002166_altered_tumor_susceptibility | 1.97179713 |
| 23 | * MP0002452_abnormal_antigen_presenting | 1.93123702 |
| 24 | * MP0002419_abnormal_innate_immunity | 1.88468878 |
| 25 | MP0008260_abnormal_autophagy | 1.86744892 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.84614680 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.84177641 |
| 28 | MP0004808_abnormal_hematopoietic_stem | 1.82385798 |
| 29 | MP0002723_abnormal_immune_serum | 1.76537531 |
| 30 | MP0004947_skin_inflammation | 1.72285299 |
| 31 | MP0003091_abnormal_cell_migration | 1.71023943 |
| 32 | * MP0002420_abnormal_adaptive_immunity | 1.69953744 |
| 33 | * MP0001819_abnormal_immune_cell | 1.69232270 |
| 34 | MP0010307_abnormal_tumor_latency | 1.65552783 |
| 35 | MP0003045_fibrosis | 1.64996597 |
| 36 | MP0005671_abnormal_response_to | 1.64001506 |
| 37 | MP0002405_respiratory_system_inflammati | 1.62409603 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.62145549 |
| 39 | MP0002398_abnormal_bone_marrow | 1.61414608 |
| 40 | MP0005025_abnormal_response_to | 1.60719762 |
| 41 | MP0005023_abnormal_wound_healing | 1.57399721 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.54486400 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.54486400 |
| 44 | MP0002006_tumorigenesis | 1.53048242 |
| 45 | MP0003763_abnormal_thymus_physiology | 1.51901462 |
| 46 | MP0006082_CNS_inflammation | 1.50477862 |
| 47 | MP0003075_altered_response_to | 1.44600655 |
| 48 | MP0003448_altered_tumor_morphology | 1.44527402 |
| 49 | MP0001958_emphysema | 1.43205903 |
| 50 | MP0003279_aneurysm | 1.41902651 |
| 51 | * MP0000716_abnormal_immune_system | 1.41572882 |
| 52 | MP0000733_abnormal_muscle_development | 1.41482749 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.41352301 |
| 54 | MP0000371_diluted_coat_color | 1.39072971 |
| 55 | MP0002933_joint_inflammation | 1.34794383 |
| 56 | MP0002722_abnormal_immune_system | 1.34744183 |
| 57 | MP0001873_stomach_inflammation | 1.34636944 |
| 58 | MP0003690_abnormal_glial_cell | 1.33987230 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.31461765 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.27014640 |
| 61 | MP0009785_altered_susceptibility_to | 1.26398713 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.23786806 |
| 63 | MP0009764_decreased_sensitivity_to | 1.19234103 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.19213341 |
| 65 | * MP0002429_abnormal_blood_cell | 1.18241291 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.14658408 |
| 67 | MP0009840_abnormal_foam_cell | 1.14504804 |
| 68 | MP0000858_altered_metastatic_potential | 1.13935035 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.13190514 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 1.11804906 |
| 71 | MP0001853_heart_inflammation | 1.11591023 |
| 72 | MP0002877_abnormal_melanocyte_morpholog | 1.09156770 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.07564076 |
| 74 | MP0005257_abnormal_intraocular_pressure | 1.07358440 |
| 75 | MP0002148_abnormal_hypersensitivity_rea | 1.07000481 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 1.05517189 |
| 77 | MP0000465_gastrointestinal_hemorrhage | 1.04669909 |
| 78 | MP0008004_abnormal_stomach_pH | 1.04448577 |
| 79 | MP0004883_abnormal_blood_vessel | 1.03895944 |
| 80 | MP0000767_abnormal_smooth_muscle | 1.01162213 |
| 81 | MP0004381_abnormal_hair_follicle | 1.00862176 |
| 82 | MP0005166_decreased_susceptibility_to | 1.00277994 |
| 83 | MP0003329_amyloid_beta_deposits | 0.99999340 |
| 84 | MP0001243_abnormal_dermal_layer | 0.95700294 |
| 85 | MP0005164_abnormal_response_to | 0.95119249 |
| 86 | MP0003866_abnormal_defecation | 0.94347802 |
| 87 | MP0001915_intracranial_hemorrhage | 0.94173268 |
| 88 | MP0005275_abnormal_skin_tensile | 0.92732379 |
| 89 | MP0001849_ear_inflammation | 0.90619244 |
| 90 | MP0001851_eye_inflammation | 0.89602110 |
| 91 | MP0000015_abnormal_ear_pigmentation | 0.87924707 |
| 92 | MP0008961_abnormal_basal_metabolism | 0.85092531 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.84764074 |
| 94 | MP0002060_abnormal_skin_morphology | 0.82632981 |
| 95 | MP0000249_abnormal_blood_vessel | 0.81722578 |
| 96 | MP0000490_abnormal_crypts_of | 0.81268751 |
| 97 | MP0003828_pulmonary_edema | 0.80815551 |
| 98 | MP0005310_abnormal_salivary_gland | 0.80206599 |
| 99 | MP0001663_abnormal_digestive_system | 0.78857415 |
| 100 | MP0005621_abnormal_cell_physiology | 0.78520892 |
| 101 | MP0010630_abnormal_cardiac_muscle | 0.78023435 |
| 102 | MP0008469_abnormal_protein_level | 0.78013678 |
| 103 | MP0002254_reproductive_system_inflammat | 0.77807388 |
| 104 | MP0000920_abnormal_myelination | 0.77032692 |
| 105 | MP0000604_amyloidosis | 0.75069713 |
| 106 | MP0005390_skeleton_phenotype | 0.74541186 |
| 107 | MP0003183_abnormal_peptide_metabolism | 0.74455779 |
| 108 | MP0000343_altered_response_to | 0.74167637 |
| 109 | MP0002168_other_aberrant_phenotype | 0.73907074 |
| 110 | MP0002019_abnormal_tumor_incidence | 0.73513963 |
| 111 | MP0005409_darkened_coat_color | 0.73267127 |
| 112 | MP0004858_abnormal_nervous_system | 0.71768466 |
| 113 | MP0005666_abnormal_adipose_tissue | 0.71228861 |
| 114 | MP0002925_abnormal_cardiovascular_devel | 0.71119476 |
| 115 | MP0003795_abnormal_bone_structure | 0.70274478 |
| 116 | MP0006054_spinal_hemorrhage | 0.67554956 |
| 117 | MP0002138_abnormal_hepatobiliary_system | 0.67236579 |
| 118 | MP0000350_abnormal_cell_proliferation | 0.66811175 |
| 119 | MP0009763_increased_sensitivity_to | 0.66385910 |
| 120 | MP0002075_abnormal_coat/hair_pigmentati | 0.63381593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral aneurysm (HP:0004944) | 3.56755027 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.43497817 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.30125138 |
| 4 | Orchitis (HP:0100796) | 3.27270231 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.17085117 |
| 6 | Abnormality of the fingertips (HP:0001211) | 2.98166173 |
| 7 | Optic neuritis (HP:0100653) | 2.97970462 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 2.97970462 |
| 9 | Recurrent fungal infections (HP:0002841) | 2.92524419 |
| 10 | Recurrent viral infections (HP:0004429) | 2.87022784 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 2.83113198 |
| 12 | Obstructive lung disease (HP:0006536) | 2.83113198 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 2.78137109 |
| 14 | Colitis (HP:0002583) | 2.69682520 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 2.63486680 |
| 16 | Absent frontal sinuses (HP:0002688) | 2.59640097 |
| 17 | Vasculitis (HP:0002633) | 2.58510780 |
| 18 | Increased density of long bones (HP:0006392) | 2.58453630 |
| 19 | Shallow orbits (HP:0000586) | 2.57239005 |
| 20 | Inflammation of the large intestine (HP:0002037) | 2.52450043 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 2.52149315 |
| 22 | Hematochezia (HP:0002573) | 2.51623552 |
| 23 | Mitral valve prolapse (HP:0001634) | 2.50749298 |
| 24 | Protrusio acetabuli (HP:0003179) | 2.48111256 |
| 25 | Periodontitis (HP:0000704) | 2.47644777 |
| 26 | Gastrointestinal stroma tumor (HP:0100723) | 2.47428317 |
| 27 | Cellulitis (HP:0100658) | 2.47160128 |
| 28 | Gastrointestinal inflammation (HP:0004386) | 2.46157728 |
| 29 | Osteolytic defects of the hand bones (HP:0009699) | 2.45606610 |
| 30 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45606610 |
| 31 | Increased cerebral lipofuscin (HP:0011813) | 2.45488666 |
| 32 | Aortic aneurysm (HP:0004942) | 2.44818694 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 2.43377802 |
| 34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.37979172 |
| 35 | Myocardial infarction (HP:0001658) | 2.37087893 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.34622692 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33024565 |
| 38 | Ulnar bowing (HP:0003031) | 2.32933561 |
| 39 | Premature rupture of membranes (HP:0001788) | 2.32914887 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.30993873 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.30993873 |
| 42 | Mucopolysacchariduria (HP:0008155) | 2.30424161 |
| 43 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.30424161 |
| 44 | Peritonitis (HP:0002586) | 2.29097142 |
| 45 | Recurrent skin infections (HP:0001581) | 2.27777946 |
| 46 | Hyperacusis (HP:0010780) | 2.27633824 |
| 47 | Gingivitis (HP:0000230) | 2.23677177 |
| 48 | Spondylolisthesis (HP:0003302) | 2.22546441 |
| 49 | Urticaria (HP:0001025) | 2.19465325 |
| 50 | Hemoptysis (HP:0002105) | 2.18927131 |
| 51 | Amyloidosis (HP:0011034) | 2.18437338 |
| 52 | Pustule (HP:0200039) | 2.17788060 |
| 53 | Panhypogammaglobulinemia (HP:0003139) | 2.17149782 |
| 54 | Genu recurvatum (HP:0002816) | 2.17019654 |
| 55 | Ankle contracture (HP:0006466) | 2.16136471 |
| 56 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.15774299 |
| 57 | Myositis (HP:0100614) | 2.15684441 |
| 58 | Dilatation of the ascending aorta (HP:0005111) | 2.15058672 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 2.13547684 |
| 60 | Disproportionate tall stature (HP:0001519) | 2.12856876 |
| 61 | Upper limb amyotrophy (HP:0009129) | 2.12415208 |
| 62 | Distal upper limb amyotrophy (HP:0007149) | 2.12415208 |
| 63 | Neurofibrillary tangles (HP:0002185) | 2.11709748 |
| 64 | Neuronal loss in central nervous system (HP:0002529) | 2.11601049 |
| 65 | Restrictive lung disease (HP:0002091) | 2.11242114 |
| 66 | Keratoconjunctivitis sicca (HP:0001097) | 2.11078737 |
| 67 | Encephalitis (HP:0002383) | 2.09856148 |
| 68 | Increased connective tissue (HP:0009025) | 2.09579295 |
| 69 | Epistaxis (HP:0000421) | 2.09468433 |
| 70 | Urethral obstruction (HP:0000796) | 2.08401427 |
| 71 | Thoracic kyphosis (HP:0002942) | 2.07646321 |
| 72 | Aortic dissection (HP:0002647) | 2.07058032 |
| 73 | Interstitial pulmonary disease (HP:0006530) | 2.03373823 |
| 74 | Purpura (HP:0000979) | 2.03217301 |
| 75 | Abnormality of the thoracic spine (HP:0100711) | 2.03202895 |
| 76 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03071821 |
| 77 | Spinal cord lesions (HP:0100561) | 1.99652537 |
| 78 | Syringomyelia (HP:0003396) | 1.99652537 |
| 79 | Upper motor neuron abnormality (HP:0002127) | 1.99427694 |
| 80 | Distal lower limb amyotrophy (HP:0008944) | 1.98983153 |
| 81 | Frequent falls (HP:0002359) | 1.96271725 |
| 82 | Abnormal platelet volume (HP:0011876) | 1.95891454 |
| 83 | Arterial thrombosis (HP:0004420) | 1.95447172 |
| 84 | Aneurysm (HP:0002617) | 1.94729839 |
| 85 | Persistence of primary teeth (HP:0006335) | 1.91697459 |
| 86 | Obstructive sleep apnea (HP:0002870) | 1.90606918 |
| 87 | Macroorchidism (HP:0000053) | 1.90585318 |
| 88 | Gingival bleeding (HP:0000225) | 1.90193239 |
| 89 | Slow saccadic eye movements (HP:0000514) | 1.89936177 |
| 90 | Cerebral inclusion bodies (HP:0100314) | 1.88997617 |
| 91 | Axonal loss (HP:0003447) | 1.88846548 |
| 92 | Broad face (HP:0000283) | 1.88265721 |
| 93 | Cervical subluxation (HP:0003308) | 1.87745324 |
| 94 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87618910 |
| 95 | Viral hepatitis (HP:0006562) | 1.86920570 |
| 96 | Lymphopenia (HP:0001888) | 1.86621712 |
| 97 | Abnormality of macrophages (HP:0004311) | 1.85255587 |
| 98 | Hand muscle atrophy (HP:0009130) | 1.85182287 |
| 99 | T lymphocytopenia (HP:0005403) | 1.84912856 |
| 100 | Spontaneous hematomas (HP:0007420) | 1.84120966 |
| 101 | Thin bony cortex (HP:0002753) | 1.82719889 |
| 102 | Keratoconjunctivitis (HP:0001096) | 1.82262013 |
| 103 | Loss of speech (HP:0002371) | 1.81434574 |
| 104 | Abnormality of the peritoneum (HP:0002585) | 1.80060439 |
| 105 | Narrow palate (HP:0000189) | 1.79774379 |
| 106 | Petechiae (HP:0000967) | 1.79448140 |
| 107 | Acrocyanosis (HP:0001063) | 1.79301394 |
| 108 | Vertebral compression fractures (HP:0002953) | 1.78778634 |
| 109 | Increased mean platelet volume (HP:0011877) | 1.78650169 |
| 110 | Emphysema (HP:0002097) | 1.78476427 |
| 111 | Polygenic inheritance (HP:0010982) | 1.78272654 |
| 112 | Increased serum ferritin (HP:0003281) | 1.78244906 |
| 113 | Atrophic scars (HP:0001075) | 1.77822007 |
| 114 | Hepatosplenomegaly (HP:0001433) | 1.77024730 |
| 115 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.76767988 |
| 116 | Chronic otitis media (HP:0000389) | 1.76692398 |
| 117 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.76492305 |
| 118 | Abnormality of T cell number (HP:0011839) | 1.76297928 |
| 119 | Dysostosis multiplex (HP:0000943) | 1.76180614 |
| 120 | Disinhibition (HP:0000734) | 1.76131862 |
| 121 | Short 4th metacarpal (HP:0010044) | 1.75847457 |
| 122 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.75847457 |
| 123 | High pitched voice (HP:0001620) | 1.74616077 |
| 124 | Leukocytosis (HP:0001974) | 1.73696125 |
| 125 | Prolonged bleeding time (HP:0003010) | 1.72650769 |
| 126 | Osteomyelitis (HP:0002754) | 1.70421391 |
| 127 | Radial bowing (HP:0002986) | 1.69749301 |
| 128 | Chest pain (HP:0100749) | 1.69213950 |
| 129 | Increased IgE level (HP:0003212) | 1.68761702 |
| 130 | Stomatitis (HP:0010280) | 1.68690573 |
| 131 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.67564897 |
| 132 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.67564897 |
| 133 | Abnormality of glycolipid metabolism (HP:0010969) | 1.67564897 |
| 134 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.66302878 |
| 135 | Striae distensae (HP:0001065) | 1.65911169 |
| 136 | Nasal polyposis (HP:0100582) | 1.65017692 |
| 137 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.63787127 |
| 138 | Meningitis (HP:0001287) | 1.63739797 |
| 139 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.63224577 |
| 140 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.63224577 |
| 141 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.63224577 |
| 142 | Agammaglobulinemia (HP:0004432) | 1.63154926 |
| 143 | Thick nail (HP:0001805) | 1.63154127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.67240353 |
| 2 | EEF2K | 3.24055068 |
| 3 | TRIB3 | 3.15425114 |
| 4 | MAP4K1 | 3.14144488 |
| 5 | CDK12 | 2.84886077 |
| 6 | TTN | 2.77530395 |
| 7 | MAP3K10 | 2.71213223 |
| 8 | PKN2 | 2.64856400 |
| 9 | TYK2 | 2.09459600 |
| 10 | JAK3 | 2.03703742 |
| 11 | CAMK1D | 1.99750740 |
| 12 | ERN1 | 1.91620296 |
| 13 | MAP2K3 | 1.87681298 |
| 14 | PTK6 | 1.80802134 |
| 15 | CAMK1G | 1.75623785 |
| 16 | STK10 | 1.74613417 |
| 17 | SIK2 | 1.73843053 |
| 18 | ZAP70 | 1.70169192 |
| 19 | MAP3K14 | 1.66665870 |
| 20 | KIT | 1.65076121 |
| 21 | SMG1 | 1.64823084 |
| 22 | CDC42BPA | 1.64326138 |
| 23 | JAK1 | 1.63656982 |
| 24 | RIPK1 | 1.61734679 |
| 25 | TBK1 | 1.59022741 |
| 26 | EPHB1 | 1.54264643 |
| 27 | CSF1R | 1.45831766 |
| 28 | HCK | 1.40239522 |
| 29 | TAOK2 | 1.39241800 |
| 30 | MAP3K11 | 1.36974969 |
| 31 | CSK | 1.35283826 |
| 32 | RIPK4 | 1.34058124 |
| 33 | TRPM7 | 1.32966165 |
| 34 | MAP3K13 | 1.28768729 |
| 35 | IKBKB | 1.28220541 |
| 36 | RPS6KA4 | 1.23301899 |
| 37 | TNK2 | 1.21887144 |
| 38 | TGFBR2 | 1.20486186 |
| 39 | LRRK2 | 1.19125249 |
| 40 | SIK1 | 1.18840395 |
| 41 | FGFR4 | 1.18376779 |
| 42 | CHUK | 1.15514536 |
| 43 | MAP3K1 | 1.14953953 |
| 44 | DMPK | 1.14830261 |
| 45 | PDGFRA | 1.13156179 |
| 46 | ITK | 1.12789604 |
| 47 | BMX | 1.12381375 |
| 48 | PAK4 | 1.08985594 |
| 49 | MATK | 1.07503381 |
| 50 | BLK | 1.06939254 |
| 51 | IKBKE | 1.06388154 |
| 52 | CDK6 | 1.06254040 |
| 53 | MTOR | 1.05942512 |
| 54 | FGFR3 | 1.03344689 |
| 55 | FES | 1.02690400 |
| 56 | SIK3 | 1.02274945 |
| 57 | PDGFRB | 0.98143006 |
| 58 | ICK | 0.97719571 |
| 59 | NEK2 | 0.97118560 |
| 60 | KSR2 | 0.97009264 |
| 61 | LCK | 0.96440706 |
| 62 | BTK | 0.95471276 |
| 63 | GRK6 | 0.95440015 |
| 64 | SCYL2 | 0.95146758 |
| 65 | PRKCH | 0.90231364 |
| 66 | TAOK3 | 0.89951492 |
| 67 | CLK1 | 0.87053695 |
| 68 | BRD4 | 0.86212277 |
| 69 | NME2 | 0.85103842 |
| 70 | ALK | 0.84099186 |
| 71 | FGR | 0.82674638 |
| 72 | IRAK2 | 0.82025671 |
| 73 | MAP3K6 | 0.81265436 |
| 74 | MAP3K7 | 0.80202396 |
| 75 | JAK2 | 0.80052784 |
| 76 | MAPK7 | 0.79700262 |
| 77 | SYK | 0.79232432 |
| 78 | PDPK1 | 0.79053474 |
| 79 | MARK3 | 0.78041629 |
| 80 | PIM1 | 0.76797240 |
| 81 | MOS | 0.75520770 |
| 82 | TAOK1 | 0.74987653 |
| 83 | CDK4 | 0.74130613 |
| 84 | IRAK4 | 0.74098817 |
| 85 | PDK1 | 0.73486954 |
| 86 | PTK2 | 0.72607369 |
| 87 | BMPR2 | 0.72500965 |
| 88 | TXK | 0.71564061 |
| 89 | PAK2 | 0.71469541 |
| 90 | MAPK12 | 0.71108283 |
| 91 | STK4 | 0.71047832 |
| 92 | GRK7 | 0.68829589 |
| 93 | HIPK2 | 0.68762746 |
| 94 | DDR2 | 0.67001572 |
| 95 | RPS6KC1 | 0.65601895 |
| 96 | RPS6KL1 | 0.65601895 |
| 97 | RET | 0.63639748 |
| 98 | IRAK1 | 0.63182622 |
| 99 | TESK2 | 0.62961873 |
| 100 | EGFR | 0.62116204 |
| 101 | FLT3 | 0.61032923 |
| 102 | STK3 | 0.59522012 |
| 103 | CDK9 | 0.58400398 |
| 104 | CAMKK1 | 0.58314281 |
| 105 | RPS6KB2 | 0.57390692 |
| 106 | MAP3K8 | 0.56758843 |
| 107 | NEK9 | 0.52322427 |
| 108 | IRAK3 | 0.52152364 |
| 109 | MARK2 | 0.51976376 |
| 110 | PRKD2 | 0.50995765 |
| 111 | MAPK11 | 0.50256743 |
| 112 | LYN | 0.48022193 |
| 113 | EPHA3 | 0.44428903 |
| 114 | CDC7 | 0.43494912 |
| 115 | YES1 | 0.42348736 |
| 116 | SGK3 | 0.41887495 |
| 117 | ABL1 | 0.41707033 |
| 118 | NLK | 0.41670850 |
| 119 | MAP3K3 | 0.40577322 |
| 120 | MAPK4 | 0.40411672 |
| 121 | TYRO3 | 0.40006701 |
| 122 | MELK | 0.37853638 |
| 123 | FYN | 0.36832547 |
| 124 | ATR | 0.36537515 |
| 125 | RPS6KA2 | 0.35783114 |
| 126 | INSR | 0.35691306 |
| 127 | MAPKAPK2 | 0.35106722 |
| 128 | RPS6KA6 | 0.34733557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.34360360 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.30560459 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.14912091 |
| 4 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.97088245 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.90541817 |
| 6 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.89708163 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.75438056 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.71552586 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66453087 |
| 10 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63950376 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.62865496 |
| 12 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.54777495 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.49862823 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47915181 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.47875185 |
| 16 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.47029547 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.46577057 |
| 18 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.45037009 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.44417448 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44224950 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42413471 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40960994 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40018005 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39669062 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39399549 |
| 26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.37972917 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37707383 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.37098623 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.36608488 |
| 30 | Lysine degradation_Homo sapiens_hsa00310 | 1.35873415 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.33745655 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.30531477 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.30070871 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.29890449 |
| 35 | Platelet activation_Homo sapiens_hsa04611 | 1.28236750 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.27371894 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25797909 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25638861 |
| 39 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.24930800 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24559293 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22241208 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21915890 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.21617505 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.20914733 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 1.20215026 |
| 46 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.19149608 |
| 47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.18739473 |
| 48 | Focal adhesion_Homo sapiens_hsa04510 | 1.15713695 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15300743 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 1.12888479 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 1.09153757 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08478173 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 1.07674756 |
| 54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.06177173 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06089288 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05380118 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04240433 |
| 58 | Adherens junction_Homo sapiens_hsa04520 | 1.01671235 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.01248823 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97660934 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 0.95948106 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95846633 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.95637036 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.95160326 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94711347 |
| 66 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.94510531 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91893295 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91524701 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91320580 |
| 70 | Colorectal cancer_Homo sapiens_hsa05210 | 0.87672456 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.86289892 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.85433031 |
| 73 | Hepatitis C_Homo sapiens_hsa05160 | 0.84613311 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83519336 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82759042 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79811660 |
| 77 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79130380 |
| 78 | Glioma_Homo sapiens_hsa05214 | 0.77602406 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77211285 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75505969 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75473879 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.73828178 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72673708 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72307525 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.72213095 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71210923 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69177540 |
| 88 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67922791 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66253238 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65779218 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64228052 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63522027 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63326016 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61791607 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61432175 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60814263 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.60543201 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60473374 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60357633 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59749893 |
| 101 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58392200 |
| 102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57380100 |
| 103 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56314587 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56225953 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56215306 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55135464 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55134661 |
| 108 | Bladder cancer_Homo sapiens_hsa05219 | 0.54934087 |
| 109 | Allograft rejection_Homo sapiens_hsa05330 | 0.54646856 |
| 110 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54223815 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51842951 |
| 112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48050379 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46408741 |

